Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
J Fish Biol ; 90(1): 265-282, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27781260

ABSTRACT

Video cameras recorded the diurnal visitation rates of transient (large home range) piscivorous fishes to coral patch reefs in The Bahamas and identified 11 species. Visits by bar jack Caranx ruber, mutton snapper Lutjanus analis, yellowtail snapper Ocyurus chrysurus, barracuda Sphyraena barracuda and cero Scomberomorus regalis were sufficiently frequent to correlate with a range of biophysical factors. Patch-reef visitation rates and fish abundances varied with distance from shore and all species except S. regalis were seen more frequently inshore. This pattern is likely to be caused by factors including close proximity to additional foraging areas in mangroves and on fore-reefs and higher abundances close to inshore nursery habitats. Visitation rates and abundances of C. ruber, L. analis, O. chrysurus and S. regalis also varied seasonally (spring v. winter), possibly as fishes responded to temperature changes or undertook spawning migrations. The abundance of each transient predator species on the patch reefs generally exhibited limited diurnal variability, but L. analis was seen more frequently towards dusk. This study demonstrates that the distribution of transient predators is correlated spatially and temporally with a range of factors, even within a single lagoon, and these drivers are species specific. Transient predators are considered an important source of mortality shaping reef-fish assemblages and their abundance, in combination with the biomass of resident predators, was negatively correlated with the density of prey fishes. Furthermore, transient predators are often targeted by fishers and understanding how they utilize seascapes is critical for protecting them within reserves.


Subject(s)
Behavior, Animal , Circadian Rhythm/physiology , Coral Reefs , Fishes/physiology , Animals , Bahamas , Biomass , Caribbean Region , Environment
2.
Mar Biol ; 163: 63, 2016.
Article in English | MEDLINE | ID: mdl-27065495

ABSTRACT

Recent studies on deep-sea sponges have focused on mapping contemporary distributions while little work has been done to map historical distributions; historical distributions can provide valuable information on the time frame over which species have co-evolved and may provide insight into the reasons for their persistence or decline. Members of the sponge family Geodiidae are dominant members of deep-sea sponge assemblages in the northwestern Atlantic. They possess unique spicules called sterrasters, which undergo little transport in sediment and can therefore indicate the Geodiidae sponge historical presence when found in sediment cores. This study focuses on the slopes of Flemish Cap and Grand Bank, important fishing grounds off the coast of Newfoundland, Canada, in international waters. Sediment cores collected in 2009 and 2010 were visually inspected for sponge spicules. Cores containing spicules were sub-sampled and examined under a light microscope for the presence of sterrasters. These cores were also dated using X-radiographs and grouped into five time categories based on known sediment horizons, ranging from 17,000 years BP to the present. Chronological groupings identified Geodiidae sponges in four persistent sponge grounds. The oldest sterrasters were concentrated in the eastern region of the Flemish Cap and on the southeastern slope of the Grand Bank. Opportunistic sampling of a long core in the southeastern region of the Flemish Cap showed the continuous presence of sponge spicules to more than 130 ka BP. Our results indicate that the geodiids underwent a significant range expansion following deglaciation, and support a contemporary distribution that is not shaped by recent fishing activity.

3.
J Fish Biol ; 88(4): 1620-30, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26840386

ABSTRACT

New records of the Japanese seahorse Hippocampus mohnikei from Cambodia, Malaysia, Thailand and Vietnam, along with recently published studies from India and Singapore, have greatly expanded the known range of H. mohnikei within Southeast Asia. These new records reveal novel habitat preferences and threats to H. mohnikei in the region. Although the global conservation status of H. mohnikei is classified as Data Deficient according to the IUCN Red List of Threatened Species, new sightings indicate that this species is found in similar habitats and faces similar threats as other Hippocampus species that are considered Vulnerable.


Subject(s)
Ecosystem , Smegmamorpha , Animals , Asia, Southeastern , Cambodia , Conservation of Natural Resources , Endangered Species , Malaysia , Thailand , Vietnam
4.
Australas Phys Eng Sci Med ; 38(1): 129-38, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25663432

ABSTRACT

Lithium fluoride thermoluminescent dosimeters (TLDs) exhibit a dependence on the energy of the radiation beam of interest so need to be carefully calibrated for different energy spectra if used for clinical radiation oncology beam dosimetry and quality assurance. TLD energy response was investigated for a specific set of TLD700:LiF(Mg,Ti) chips for a high dose rate (192)Ir brachytherapy source. A novel method of energy response calculation for (192)Ir was developed where dose was determined through Monte Carlo modelling in Geant4. The TLD response was then measured experimentally. Results showed that TLD700 has a depth dependent response in water ranging from 1.170 ± 0.125 at 20 mm to 0.976 ± 0.043 at 50 mm (normalised to a nominal 6 MV beam response). The method of calibration and Monte Carlo data developed through this study could be easily applied by other Medical Physics departments seeking to use TLDs for (192)Ir patient dosimetry or treatment planning system experimental verification.


Subject(s)
Brachytherapy , Computer Simulation , Iridium Radioisotopes/chemistry , Radiometry , Humans , Monte Carlo Method , Radiotherapy Dosage
5.
J Fish Biol ; 86(1): 1-15, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25307290

ABSTRACT

Life-history variables for three incidentally captured species of seahorse (Kellogg's seahorse Hippocampus kelloggi, the hedgehog seahorse Hippocampus spinosissimus and the three-spot seahorse Hippocampus trimaculatus) were established using specimens obtained from 33 fisheries landing sites in Peninsular Malaysia. When samples were pooled by species across the peninsula, sex ratios were not significantly different from unity, and height and mass relationships were significant for all species. For two of these species, height at physical maturity (HM ) was smaller than the height at which reproductive activity (HR ) commenced: H. spinosissimus (HM = 99·6 mm, HR = 123·2 mm) and H. trimaculatus (HM = 90·5 mm, HR = 121·8 mm). For H. kelloggi, HM could not be estimated as all individuals were physically mature, while HR = 167·4 mm. It appears that all three Hippocampus spp. were, on average, caught before reproducing; height at 50% capture (HC ) was ≥HM but ≤HR . The results from this study probe the effectiveness of assessment techniques for data-poor fisheries that rely heavily on estimates of length at maturity, especially if maturity is poorly defined. Findings also question the sustainability of H. trimaculatus catches in the south-west region of Peninsular Malaysia, where landed specimens had a notably smaller mean height (86·2 mm) and markedly skewed sex ratio (6% males) compared with samples from the south-east and north-west of the peninsula.


Subject(s)
Fisheries , Smegmamorpha/physiology , Animals , Body Size , Conservation of Natural Resources , Female , Life Cycle Stages , Malaysia , Male , Population Dynamics , Sex Ratio
6.
Br J Radiol ; 86(1026): 20130058, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23520225

ABSTRACT

OBJECTIVE: Brachytherapy employing iodine-125 seeds is an established treatment for low-risk prostate cancers. Post-implant dosimetry (PID) is an important tool for identifying suboptimal implants. The aim of this work was to improve suboptimal implants by a subsequent iodine-125 seed top-up (reimplantation), based on the PID results. METHODS: Of 255 patients treated between 2009 and 2012, 6 were identified as having received suboptimal implants and were scheduled for seed top-up. Needle configurations and the number of top-up seeds were determined based on post-implant CT images as well as a reimplantation treatment plan. An average of 14 seeds per patient were implanted during each top-up. Dosimetric outcome was assessed via target parameters and doses received by organs at risk. RESULTS: All six patients had a successful top-up, with a 67% increase in the mean dose delivered to 90% of the prostate volume and a 40% increase in the volume that receives 100% of the prescribed dose. However, the final dosimetric assessment was based on the same seed activity, as the planning system does not account for the decay of the initially implanted seeds. Although physical dosimetry is not influenced by different seed activities (doses are calculated to infinity), the radiobiological implications might be slightly different from the situation when optimal implantation is achieved with one treatment only. CONCLUSION: Seed reimplantation in suboptimal prostate implants is feasible and leads to successful clinical outcomes. ADVANCES IN KNOWLEDGE: Suboptimal prostate implants can occur for various reasons. This work shows that seed reimplantation as salvage therapy can lead to an optimal dosimetric outcome with manageable normal tissue effects.


Subject(s)
Brachytherapy/methods , Iodine Radioisotopes/therapeutic use , Neoplasm Recurrence, Local/prevention & control , Prostatic Neoplasms/radiotherapy , Feasibility Studies , Humans , Male , Prostatic Neoplasms/pathology , Radiometry/methods , Radiotherapy Dosage , Reproducibility of Results , Treatment Outcome
7.
Med Sante Trop ; 22(1): 82-3, 2012.
Article in French | MEDLINE | ID: mdl-22868733

ABSTRACT

The purpose of this report is to describe the first case of infection with Histoplasma capsulatum variety duboisii in Gabon, in a patient with HIV infection.


Subject(s)
Dermatomycoses , Histoplasmosis , Adult , Dermatomycoses/diagnosis , Gabon , Histoplasmosis/diagnosis , Humans , Male
8.
J Radiol Prot ; 32(3): 339-47, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22854245

ABSTRACT

Treatment of low grade prostate cancer with permanent implant of radioactive seeds has become one of the most common brachytherapy procedures in use today. The implant procedure is usually performed with fluoroscopy image guidance to ensure that the seeds are deployed in the planned locations. In this situation the physician performing the transperineal implant is required to be close to the fluoroscopy unit and dose to the eye lens may be of concern. In 1991 the International Commission on Radiological Protection (ICRP) provided a recommended dose limit of 150 mSv yr(-1) for occupational exposures to the lens of the eye. With more long term follow-up data, this limit was revised in 2011 to 20 mSv yr(-1). With this revised limit in mind, we have investigated the dose to the lens of the eye received by physicians during prostate brachytherapy seed implantation. By making an approximation of annual workload, we have related the dose received to the annual background dose. Through clinical and phantom measurements with thermoluminescent dosimeters, it was found that the excess dose to the physician's eye lens received for a conservative estimate of annual workload was never greater than 100% of the annual background dose.


Subject(s)
Brachytherapy/instrumentation , Iodine Radioisotopes/therapeutic use , Lens, Crystalline/radiation effects , Occupational Exposure/adverse effects , Physicians , Prostatic Neoplasms/radiotherapy , Radioisotopes/therapeutic use , Calibration , Fluoroscopy , Humans , Male , Monte Carlo Method , Phantoms, Imaging , Radiation Dosage , Radiation Monitoring
9.
Bull Soc Pathol Exot ; 105(1): 1-4, 2012 Feb.
Article in French | MEDLINE | ID: mdl-22170406

ABSTRACT

According to WHO estimates, between 1 and 20% of tuberculosis cases in the world are multiresistant. In Gabon, this prevalence is estimated at 1.9%. In this forward-looking study from March 2006 to August 2010, we report 16 cases of multi-resistant tuberculosis out of 24 suspected resistant samples (persistence of the clinical and radiological signs after three months of well conducted treatment with first-line anti-tuberculous drugs). This study is realized in association with the laboratory of mycobacterium of the Percy military teaching hospital, Clamart, France.


Subject(s)
Tuberculosis, Multidrug-Resistant/diagnosis , Tuberculosis, Multidrug-Resistant/therapy , Adult , Antitubercular Agents/classification , Antitubercular Agents/therapeutic use , Cohort Studies , Drug Resistance, Multiple, Bacterial , Female , Gabon/epidemiology , Hospitals, Military/statistics & numerical data , Humans , Male , Microbial Sensitivity Tests , Mycobacterium tuberculosis/classification , Mycobacterium tuberculosis/physiology , Tuberculosis, Multidrug-Resistant/epidemiology , Young Adult
10.
Sante ; 21(2): 79-81, 2011.
Article in French | MEDLINE | ID: mdl-21896441

ABSTRACT

OBJECTIVES: this study aims to assess the frequency, complications and advantages of each of the three principal approaches to hysterectomies: abdominal, vaginal, and laparoscopic. PATIENTS AND METHOD: this prospective study analyses a consecutive series of 78 hysterectomies for benign disease (myomas and precancerous lesions of the cervix) in the gynaecological surgery department of Libreville Hospital Centre from March 1, 2006, to November, 2010. We excluded cases of genital prolapsus, invasive uterine cancer, and hysterectomy during pregnancy or delivery. Data were collected from the surgical registers and reports and from patients' files. RESULTS: the frequency of abdominal hysterectomy was about 39% (31 cases), and that of vaginal hysterectomy 61% (31 cases); laparoscopic assistance was involved in 20.58% (14 cases). The women's mean age was 46  years (range: 45 to 60  years). Mean parity was 5.5 (range: 0 to 9). Overall, 30% of the patients had previously undergone pelvic surgery by the abdominal route. Two wounds, one of the bladder and the other of the uterus, comprised the surgical morbidity. No deaths occurred. CONCLUSION: the surgeon's experience with the vaginal route, sometimes with laparoscopic assistance, resulted in limited use of the abdominal route.


Subject(s)
Hysterectomy/methods , Female , Gabon , Humans , Hysterectomy/statistics & numerical data , Laparoscopy , Middle Aged , Prospective Studies
11.
Med Trop (Mars) ; 70(4): 406, 2010 Aug.
Article in French | MEDLINE | ID: mdl-22368945

ABSTRACT

UNLABELLED: Neuromeningeal cryptococcosis occurs mainly in immunodepressed patients and especially AIDS patients. The purpose of this study was to determine the clinical and prognostic features of this severe brain infection. PATIENTS AND METHODS: This retrospective study was carried out on HIV-infected patients hospitalized for cryptococcal meningitis in the internal medicine unit of a military hospital in Libreville, Gabon from January 1, 2006 to November 31, 2009. RESULTS: Eleven cases of cryptococcosis were identified among a total of 290 cases of AIDS. Mean patient age was 39 years. The main clinical manifestation was headache that was either isolated or associated with other cerebral signs. In all cases, cerebrospinal fluid analysis demonstrated a clear aseptic aspect with direct examination after addition of India ink showing the presence of encapsulated yeast cells identified as cryptococcus. The patient was treated with amphotericin B and fluconazole. The mortality rate was 81.8% (9/11 cases). CONCLUSION: Since the manifestations of cryptococcosis during clinical AIDS are non-specific, systematic screening is recommended in AIDS patients. Early treatment could reduce mortality.


Subject(s)
Acquired Immunodeficiency Syndrome/epidemiology , Meningitis, Cryptococcal/epidemiology , Adult , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Female , Fluconazole/therapeutic use , Humans , Immunocompromised Host , Male , Meningitis, Cryptococcal/drug therapy , Middle Aged , Retrospective Studies , Young Adult
12.
Med Trop (Mars) ; 69(5): 501-2, 2009 Oct.
Article in French | MEDLINE | ID: mdl-20025184

ABSTRACT

Acute forms of meningo-encephalitis due to West Nile virus are rare. The purpose of this report is to describe the first case of acute meningoencephalitis due to West Nile virus diagnosed in Gabon. The patient was a 20-year-old Gabonese man. Diagnostic was confirmed by molecular biology. The patient died 12 days after admission to the hospital. This case is discussed based on a review of the literature.


Subject(s)
Meningitis, Viral/diagnosis , West Nile Fever/diagnosis , DNA, Viral/isolation & purification , Fatal Outcome , Gabon , Humans , Male , Reverse Transcriptase Polymerase Chain Reaction , West Nile virus/isolation & purification , Young Adult
13.
Clin Exp Immunol ; 154(3): 353-9, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19037920

ABSTRACT

Type I diabetes (T1D) is a T cell-mediated autoimmune disease characterized by loss of tolerance to islet autoantigens, leading to the destruction of insulin-producing beta cells. Peripheral tolerance to self is maintained in health through several regulatory mechanisms, including a population of CD4+CD25hi naturally occurring regulatory T cells (T(regs)), defects in which could contribute to loss of self-tolerance in patients with T1D. We have reported previously that near to T1D onset, patients demonstrate a reduced level of suppression by CD4+CD25hi T(regs) of autologous CD4+CD25- responder cells. Here we demonstrate that this defective regulation is also present in subjects with long-standing T1D (> 3 years duration; P = 0.009). No difference was observed in forkhead box P3 or CD127 expression on CD4+CD25hi T cells in patients with T1D that could account for this loss of suppression. Cross-over co-culture assays demonstrate a relative resistance to CD4+CD25hi T(reg)-mediated suppression within the CD4+CD25- T cells in all patients tested (P = 0.002), while there appears to be heterogeneity in the functional ability of CD4+CD25hi T(regs) from patients. In conclusion, this work demonstrates that defective regulation is a feature of T1D regardless of disease duration and that an impaired ability of responder T cells to be suppressed contributes to this defect.


Subject(s)
Diabetes Mellitus, Type 1/immunology , Self Tolerance/immunology , T-Lymphocytes, Regulatory/immunology , Adult , CD4 Lymphocyte Count , Cell Proliferation , Cells, Cultured , Coculture Techniques , Forkhead Transcription Factors/blood , Humans , Interleukin-2 Receptor alpha Subunit/blood , Interleukin-7 Receptor alpha Subunit/blood , Lymphocyte Activation/immunology , Middle Aged
14.
Clin Cancer Res ; 7(3): 691-703, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11297266

ABSTRACT

CD40 binding produces multifaceted growth signals in normal and malignant B cells, whereas its physiological role is less well characterized in epithelial cancers. We examined the growth outcome of CD40 ligation in human breast cancer cells, using CD40+ (T47D and BT-20) and CD40-negative (MCF-7, ZR-75-1) cell lines as defined by flow cytometric analysis, immunohistochemistry, and reverse transcription-PCR. Treatment with the soluble recombinant CD40 ligand (CD40L) molecules gp39 or CD40L-trimer significantly reduced [3H]thymidine uptake in BT-20 and T47D cells by up to 40%, but did not affect the growth of CD40-negative MCF-7 or ZR-75-1 cells. Similarly, significant growth inhibition was observed after co-incubation with CD40L-transfected murine L cells (55.0 +/- 8.9%, P < 0.001) that express membrane CD40L constitutively, or with paraformaldehyde-fixed, CD3+ CD40L+ PBLs from three different HLA-mismatched donors (39.7 +/- 3.7%, P < 0.01). Untransfected L cells and non-CD40L-expressing lymphocytes did not produce significant growth inhibition. The in vivo antitumorigenic effects of CD40L were examined using a s.c. severe combined immunodeficient-hu xenograft model. Pretreatment with two different soluble recombinant CD40L constructs (CD40L and gp39) produced similar xenograft growth-inhibitory effects [67 +/- 24% (n = 4), and 65 +/- 14% (n = 8) inhibition, respectively], which were reversed by co-treatment with the CD40L-neutralizing antibody LL48. In vitro analysis indicated that CD40L-induced growth inhibition was accompanied by apoptotic events including cell shrinkage, rounding, and detachment from the adherent T47D culture monolayer. Thirty-one and 27% of gp39-treated T47D and BT-20 cells underwent apoptosis, respectively, as compared with 56 and 65% from the same cell lines after treatment with the Fas agonistic antibody CH-11. An up-regulation of the proapoptotic protein Bax in T47D and BT-20 cells was observed, which indicated that this Bcl-2 family member may contribute to this growth-inhibitory effect. To explore the clinical relevance of CD40L-CD40 interaction, retrospective immunohistochemical analysis was carried to characterize in situ CD40- and CD40L-expression in breast cancer patient biopsies. All of the infiltrating ductal (5 of 5 cases tested) and lobular (4 of 4 cases) breast carcinomas, carcinomas in situ (6 of 6 cases), and mucinous carcinoma tested (1 case) expressed CD40. Varying proportions of tumor cells also expressed CD40L in the majority of infiltrating ductal (3 of 5 cases) and lobular (3 of 4 cases) carcinomas, and carcinomas in situ (4 of 6 cases), as determined by immunohistochemistry and validated by RT-PCR detection of the CD40L message in only CD40L positive-staining cases. Tumor infiltrating mononuclear cells from infiltrating carcinomas and carcinomas in situ expressed CD40 (10 of 10 cases), but less commonly CD40L (1 case of infiltrating lobular carcinoma, 2 cases of carcinoma in situ). Our findings indicate that the CD40 signaling pathway is active in human breast carcinoma cells. However, tumor-infiltrating lymphocytes from primary tumor tissues may be limited in their capacity to directly modulate tumor growth through the CD40L-CD40 loop.


Subject(s)
Breast Neoplasms/drug therapy , Breast Neoplasms/metabolism , CD40 Ligand/biosynthesis , CD40 Ligand/pharmacology , Animals , Annexin A5/metabolism , Apoptosis , Blotting, Western , CD40 Antigens/metabolism , Carcinoma/metabolism , Cell Division/drug effects , Dimerization , Flow Cytometry , Humans , Immunohistochemistry , In Situ Nick-End Labeling , Leukocytes, Mononuclear/metabolism , Mice , Mice, SCID , Neoplasm Transplantation , Recombinant Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Ribonucleases/metabolism , Thymidine/metabolism , Time Factors , Transfection , Tumor Cells, Cultured , Up-Regulation
15.
Br J Radiol ; 74(877): 56-61, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11227778

ABSTRACT

The phenomenon of hyper-radiosensitivity (HRS) to very low acute single doses of radiation has been demonstrated in several cell lines in vitro and in vivo, and has been studied in theory and in practice. The theory suggests a similar hypersensitivity when cells are continuously exposed to radiation at very low dose rates. These low dose rates are used when radioactive seed (iodine-125 or palladium-103) implants of the prostate are used as an alternative to surgery or external beam radiotherapy. To investigate the radiobiology of hypersensitivity of this type on various cell lines in vitro, an iodine-125 seed irradiator has been designed and built for safe use in the Gray Laboratory. In practice, the calculated dose rate has been used for consistency. Discrepancies between calculated and measured dose rates are discussed.


Subject(s)
Brachytherapy , Iodine Radioisotopes , Radiobiology/instrumentation , Cell Line/radiation effects , Cell Survival/radiation effects , Equipment Design , Humans , Radiation Dosage , Radiometry/methods
17.
Am J Clin Oncol ; 23(5): 463-72, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11039505

ABSTRACT

The purpose of this study is to determine immune recovery and function after treatment with docetaxel or paclitaxel. Peripheral blood mononuclear cells were harvested before chemotherapy and at weekly times afterwards for cycle 1. Leukocyte subsets ICD45hiCD14lo polymorphonuclear neutrophils, CD45hiCD14hi monocytes, CD45hiCD14- lymphocytes, CD3+CD4/CD8+ T cells, CD3-CD19+ B cells, CD3-CD16/CD56+ natural killer (NK) cells], and circulating cytokine levels [tumor necrosis factor-alpha, gamma-interferon (gamma-IFN), and interleukins (IL-2, IL-10, IL-12)] were followed. In addition, T-cell mitogenic function, NK function, and lymphokine activated killer (LAK) function was assessed. Ten patients were entered in the trial. T-cell frequency, B-cell frequency, and CD4/CD8 ratio did not change. IL-10 serum levels significantly decreased in paclitaxel-treated patients (4.4+/-1.3 pg/ml at week 4 versus 7.8+/-2.1 pg/ml at baseline; p < 0.05). IL-2, IL-12, and gamma-IFN levels were not detectable. NK cytotoxic activity decreased in docetaxel-treated patients. LAK cell activity was not altered. Four patients achieved a partial or complete response. They demonstrated higher than normal CD4:CD8 T-cell ratios and an improved phytohemagglutinin stimulation index (SI = 2.5). In conclusion, our findings suggest that immune function was affected more significantly after docetaxel treatment. Investigational approaches, which enhance cellular immunity, may be of greater relevance after treatment with docetaxel. Additional studies monitoring NK function after chemotherapy are recommended.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Cytokines/blood , Cytotoxicity, Immunologic/drug effects , Immunity, Cellular/drug effects , Killer Cells, Natural , Paclitaxel/analogs & derivatives , Paclitaxel/pharmacology , Taxoids , Aged , Antineoplastic Agents, Phytogenic/therapeutic use , Docetaxel , Female , Humans , Immunophenotyping , Killer Cells, Lymphokine-Activated , Killer Cells, Natural/drug effects , Lymphocyte Activation , Lymphocyte Subsets , Male , Middle Aged , Neoplasms/drug therapy , Neoplasms/immunology , Paclitaxel/therapeutic use
18.
Br J Ophthalmol ; 84(5): 517-22, 2000 May.
Article in English | MEDLINE | ID: mdl-10781517

ABSTRACT

AIM: To determine whether there are differences in the lymphocytic cell infiltrate present in affected extraocular muscles (EOM) during early and late stages of thyroid associated ophthalmopathy (TAO). METHODS: 17 biopsies of affected EOMs were collected from two groups of TAO patients (n=14): the first of five patients with early, active TAO, and the second of nine patients with late, inactive TAO. The control group was of EOM biopsies taken from 14 non-TAO patients undergoing squint surgery. Immunohistochemical analysis was undertaken using the relevant monoclonal antibodies and an avidin-biotin system and the three groups compared. RESULTS: Both CD4+ and CD8+ T cells were found in the cellular infiltrate in early, active TAO specimens which were much less evident either in late, inactive stage disease or in control tissue. There was also a significant increase in both CD45RO+ and CD45RB+ cells and macrophages in early TAO compared with the others. Increased expression of HLA-DR antigen by interstitial cells including fibroblasts was detected in both early and late disease but the EOM fibres remained morphologically intact and did not express MHC class II antigens at any time. CONCLUSION: These results demonstrate that T cells are only significantly present in early disease but increased HLA-DR antigen expression on fibroblasts is observed at all stages. This suggests that T cells are much more involved in the early than the later stages of the disease process and that early activation of fibroblasts occurs. Early intervention with immunosuppressive therapy to downregulate cytokine production by T cells may significantly influence the sequelae caused by EOM fibrosis.


Subject(s)
Fibroblasts/immunology , Graves Disease/immunology , Oculomotor Muscles/immunology , T-Lymphocyte Subsets/immunology , Adult , Aged , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Disease Progression , Female , HLA-DR Antigens/analysis , Humans , Immunoenzyme Techniques , Leukocyte Common Antigens/analysis , Male , Middle Aged
19.
Am J Gastroenterol ; 94(10): 2885-9, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10520838

ABSTRACT

OBJECTIVE: Helicobacter pylori (H. pylori) infection has been linked to gastric cancer. The factors that promote carcinogenesis remain unknown. Epidermal growth factor (EGF) has been shown to be a potent epithelial mitogen and oncoprotein when sustained over expression occurs. Our aim was to compare gastric mucosal levels of EGF and its receptor (EGFR) among controls, H. pylori infected subjects, and subjects following H. pylori eradication using quantitative flow cytometric analysis. METHODS: Patients referred for evaluation of dyspepsia underwent EGD and six antral biopsies were performed (two each for rapid urease testing (RUT), histopathology, and flow cytometry). Controls were those found to be H. pylori negative while subjects had confirmed infection. The study patients were treated, then had repeat EGD with biopsies. RESULTS: There were 17 controls and 28 cases. Mean EGF and EGFR values were 2.69 and 2.46 for controls and 4.67 and 4.64 for subjects. Subjects' mean EGF was 73% higher (p = .035) and EGFR was 88% higher (p = 0.029) than controls. After treatment, the subjects' mean values declined 55% (p = 0.0001) for EGF and 40% (p = 0.002) for EGFR. Three subjects had persistent infection and showed no change in their EGF/EGFR levels. No difference was found among factor levels with respect to endoscopic findings. CONCLUSIONS: Both EGF and EGFR from gastric antral biopsies are increased nearly 2-fold in infection with H. pylori. Infection eradication reduces levels of both factors to those of controls. One major pathogenic mechanism for gastric mucosal hyperproliferation and possibly carcinogenesis related to H. pylori may be the over expression of EGF and increased receptor density of EGFR on gastric mucosal cells.


Subject(s)
Epidermal Growth Factor/metabolism , ErbB Receptors/metabolism , Gastric Mucosa/metabolism , Helicobacter Infections/drug therapy , Helicobacter pylori , Adult , Antacids/therapeutic use , Anti-Bacterial Agents , Anti-Ulcer Agents/therapeutic use , Biopsy , Bismuth/therapeutic use , Chronic Disease , Drug Therapy, Combination/therapeutic use , Female , Flow Cytometry , Gastric Mucosa/pathology , Gastritis/microbiology , Gastritis/pathology , Helicobacter Infections/metabolism , Helicobacter Infections/microbiology , Helicobacter pylori/isolation & purification , Humans , Male , Middle Aged , Omeprazole/therapeutic use , Organometallic Compounds/therapeutic use , Prospective Studies , Salicylates/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...